Ann Arbor company’s database licensed by AstraZeneca

Multi-national pharmaceutical company AstroZeneca has licensed a database created by Ann Arbor start-up Compendia Bioscience, Inc., created for cancer profiling.

Multi-national pharmaceutical company AstraZeneca International has licensed a database created by Ann Arbor start-up Compendia Bioscience, Inc., created for cancer profiling.

Excerpt:

Officials at Compendia Bioscience Inc. of Ann Arbor said the recent deal with the $69 billion London-based drugmaker takes its product’s market penetration into 10 of the top 20 pharma companies in the world.

Read the entire article here.

Author

Our Partners

City of Oak Park

Don't miss out!

Everything Detroit, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.